Discover the immense potential of the longevity biotech field with insights from biotech investor Karl Pfleger. Learn about the explosive growth of longevity companies, the trillion-dollar market opportunities, and the key scientific areas driving the field forward. If you're an investor looking for the next big thing, you won't want to miss this episode.

The field of aging research is undergoing a revolution, and the Buck Institute is at the forefront of this transformative movement. In this captivating interview, Dr. Eric Verdin shares insights into the groundbreaking discoveries that are redefining our understanding of the aging process. From senescence and epigenetics to NAD metabolism and ketones, learn about the cutting-edge science that is paving the way for a future where age-related diseases are a thing of the past. Join us as we explore the exciting possibilities of the longevity revolution.

Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and technologies. Lucio Iannone, a leading investor at Leaps, shares insights into their unique approach and the future of healthcare.

What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville shares his biggest takeaways, from the importance of founder-market fit to the need to challenge assumptions in a nascent field.

In this insightful podcast episode, Dr. Jeff Karp shares powerful strategies to tap into your brain's neuroplasticity and rewire it for success. Discover how small changes in your daily life can lead to significant improvements in creativity, problem-solving, and overall well-being. Learn to intercept routine patterns and algorithms that limit your potential, and embrace a mindset of continuous learning and growth. Dr. Karp's new book, called LIT: Life Ignition Tools and his research at Harvard Medical School and MIT provides a scientific foundation for these life-changing techniques.

The Buck Institute, a pioneer in aging research, is uncovering how ketones impact healthspan. Dr. Brianna Stubbs, a world-champion athlete turned researcher, shares insights on how these molecules are more than just an energy source. They act as potent signaling molecules, influencing key aging pathways. Learn about the institute's groundbreaking work and how ketone drinks might help us live better, longer.

Join Jess Larsen and guest Greg Bailey in an insightful episode on "Longevity for Investors." Learn about transforming health and investing from a medical doctor turned entrepreneur with a track record in building billion-dollar companies.

Discover the market potential of longevity drugs, the importance of great management, and the criteria for evaluating successful ventures. Greg shares personal success stories and offers valuable advice for new investors in the longevity sector.

Raising money for longevity research can be a daunting task, especially for founders without a traditional biotech background. Akshay Sangahvi shares his experiences and insights on overcoming these challenges and securing funding for Yuvan Research.